Related Experiment Video
Updated: Jun 5, 2025

04:04
Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
361
The Effectiveness of Caffeine in Reducing Constipation in Adults: A Systematic Review
Anya Latthe1, Albert Tan2, Pallavi Latthe2
1Barnsley Hospital NHS Foundation Trust, Barnsley, UK. anya.latthe@nhs.net.
International Urogynecology Journal
|December 12, 2024
Summary
Caffeine
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Constipation affects 14% globally, characterized by infrequent stools or difficult passage.
- Caffeine is hypothesized to stimulate colonic motility, potentially acting as a laxative.
- Existing research on caffeine's laxative effect presents conflicting outcomes.
Purpose of the Study:
- To systematically review and assess the effectiveness of caffeine in alleviating constipation among adults.
- To synthesize findings from existing literature regarding caffeine's impact on bowel regularity.
Main Methods:
- A comprehensive literature search was conducted across multiple databases (Cochrane Library, MEDLINE, EMBASE, etc.).
- Search terms included "constipation," "faecal impaction," and "caffeine" in various forms.
- Eight studies were included, with risk of bias assessed using ROBINS-I and other tools.
Main Results:
- Studies examined caffeine from coffee, tea, energy drinks, cocoa, and kombucha.
- Four studies suggested potential effectiveness of caffeine for constipation relief.
- Four studies indicated no improvement or an exacerbation of constipation symptoms.
- Meta-analysis was not feasible due to heterogeneity in interventions and outcome measures.
Conclusions:
- The current evidence on caffeine's effectiveness for constipation is contradictory.
- Further high-quality randomized controlled trials (RCTs) are necessary to definitively establish caffeine's role in managing adult constipation.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
134
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
134
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
186
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
186
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
209
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
209
Drugs Affecting GI Tract Motility: Other Laxatives
169
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
169
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
Adrenergic Agonists: Mixed-Action Agents
663
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
663

